Ella
Product Images NDC 53002-2630

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ella (NDC 53002-2630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ulipristal Acetate Structural Formula (Ella Tablet 1)

Chemical structure of the active ingredient in Ella, as shown by the black skeletal formula with various functional groups, including acetate esters and a dimethylamino group attached to aromatic and steroidal rings.*

FDA Label Image

Figure 1 (Figure1color)

Pharmacokinetic profile chart showing the concentration (ng/mL) of ulipristal acetate and its metabolite monodemethyl-ulipristal acetate over time (hours). The chart plots concentration on a logarithmic y-axis against time on the x-axis, with ulipristal acetate represented by blue squares and monodemethyl-ulipristal acetate by red circles, including error bars.*

FDA Label Image

Label Image (Lbl530022630)

Packaging label for Ella 30 mg tablet, containing ulipristal acetate as the active ingredient. The label includes dosage instructions to take one tablet as a single dose. It is labeled for prescription use only and distributed by RPK Pharmaceuticals, Inc. The package shown is a single card.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.